Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6.27B
sum of reported positions
Reported positions
833
Changes vs prior quarter
994
141 new · 267 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 6 quarters, the typical new or larger position finished −3.3 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.05M | $146M | 2.3% | |
| 333K | $83.8M | 1.3% | |
| 223K | $76.6M | 1.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.73B | $6.27B |
| Positions | 959 | 833 |
| Biggest line | — | Intel 2% |
| 957K |
| $74.9M |
| 1.2% |
| 403K | $73M | 1.2% |
| 696K | $71.2M | 1.1% |
| 76K | $70.7M | 1.1% |
| 176K | $69.9M | 1.1% |
| 514K | $69.6M | 1.1% |
| 922K | $68.6M | 1.1% |
| 1.66M | $68.6M | 1.1% |
| 65K | $68.2M | 1.1% |
| 396K | $66.5M | 1.1% |
| 680K | $65.3M | 1.0% |
| 236K | $65.1M | 1.0% |
| 409K | $62M | 1.0% |
| 660K | $60.5M | 1.0% |
| 571K | $59.1M | 0.9% |
| 151K | $54.8M | 0.9% |
| 849K | $54.5M | 0.9% |
| 185K | $54.3M | 0.9% |
| 1.57M | $50.2M | 0.8% |
| 642K | $49.9M | 0.8% |
| 176K | $49.9M | 0.8% |
| 268K | $48.2M | 0.8% |
American States Water Company (AWR)
6,714 shares
Zentalis Pharmaceuticals (ZNTL)
112K shares
Flowco (FLOC)
25K shares
Firstsun Capital Bancorp (FSUN)
8,148 → 14K shares (+70%)
Intuitive Surgical (ISRG)
94K → 1,344 shares (−99%)
Polaris (PII)
34K → 7,798 shares (−77%)
Karyopharm Therapeutics (KPTI)
25K → 55K shares (+118%)
Emergent Biosolutions (EBS)
156K → 63K shares (−60%)
Rmr Group (RMR)
10K → 26K shares (+156%)
HINGHAM INSTN SVGS MASS
2,080 → 1,720 shares (−17%)
Docusign (DOCU)
12K shares
Johnson Outdoors (JOUT)
8,500 → 11K shares (+30%)
Larimar Therapeutics (LRMR)
165K shares
Haverty Furniture Companies (HVT)
9,540 → 20K shares (+105%)
Iheartmedia (IHRT)
101K → 116K shares (+15%)
THERAVANCE BIOPHARMA INC
24K → 29K shares (+20%)
Agenus (AGEN)
159K shares
Investors Title (ITIC)
3,866 → 1,766 shares (−54%)
Design Therapeutics (DSGN)
33K shares
WisdomTree Investments, Inc. (WT)
82K → 28K shares (−66%)
Keros Therapeutics (KROS)
45K shares
Xeris Biopharma Holdings (XERS)
60K shares
Imperial Petroleum Inc./Marshall Islands (IMPP)
84K → 104K shares (+24%)
Auna (AUNA)
101K → 91K shares (−10%)
Vipshop Holdings (VIPS)
132K → 35K shares (−74%)
